Notices. DEPARTMENT OF JUSTICE
745 words·~3 min read·
/register/2011/02/23/2011-3945A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4410-FY-P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Industrial Macromolecular Crystallography Association Correction In notice document 2011—2412 appearing on page 6497 in the issue of Friday, February 4, 2011, make the following corrections: 1. On page 6497, in the second column, in the document's subject, “Notice Pursuant to the National Cooperative Research and Production Act of 1993—Industrial Nacromolecular Crystallography Association” should read “Notice Pursuant to the National Cooperative Research and Production Act of 1993—Industrial Macromolecular Crystallography Association”. 2.
On the same page, in the second column, in the fourth line from the bottom, “Industrial Nacromolecular” should read “Industrial Macromolecular.” 3. On the same page, in the second column, in the third line from the bottom, “(“INCA”)” should read “(“IMCA”)”. 4. On the same page, in the third column, in the fifth line of the second paragraph, “INCA” should read “IMCA”. 5. On the same page, in the third column, in the first line of the third paragraph, “INCA” should read “IMCA”. [FR Doc.
C1-2011-2412 Filed 2-22-11; 8:45 am] BILLING CODE 1505-01-D DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in schedule I or II, and prior to issuing a regulation under 21 U.S.C. 952(a)(2) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing.
Therefore, in accordance with 21 CFR 1301.34(a), this is notice that on January 4, 2011, Sigma Aldrich Manufacturing LLC., 3500 Dekalb Street, St. Louis, Missouri 63118, made application by renewal to the Drug Enforcement Administration
(DEA)to be registered as an importer of the following basic classes of controlled substances: Drug Schedule Cathinone
(1235)I Methcathinone
(1237)I Aminorex
(1585)I Gamma Hydroxybutyric Acid
(2010)I Methaqualone
(2565)I Alpha-ethyltryptamine
(7249)I Ibogaine
(7260)I Lysergic acid diethylamide
(7315)I Marihuana
(7360)I Tetrahydrocannabinols
(7370)I Mescaline
(7381)I 4-Bromo-2,5-dimethoxyamphetamine
(7391)I 4-Bromo-2,5-dimethoxyphenethylamine
(7392)I 4-Methyl-2,5-dimethoxyamphetamine
(7395)I 2,5-Dimethoxyamphetamine
(7396)I 3,4-Methylenedioxyamphetamine
(7400)I N-Hydroxy-3,4-methylenedioxyamphetamine
(7402)I 3,4-Methylenedioxy-N-ethylamphetamine
(7404)I 3,4-Methylenedioxymethamphetamine
(7405)I 4-Methoxyamphetamine
(7411)I Bufotenine
(7433)I Diethyltryptamine
(7434)I Dimethyltryptamine
(7435)I Psilocybin
(7437)I Psilocyn
(7438)I 1-[1-(2-Thienyl)cyclohexyl]piperidine
(7470)I N-Benzylpiperazine
(7493)I Heroin
(9200)I Normorphine
(9313)I Etonitazene
(9624)I Amphetamine
(1100)II Methamphetamine
(1105)II Methylphenidate
(1724)II Amobarbital
(2125)II Pentobarbital
(2270)II Secobarbital
(2315)II Glutethimide
(2550)II Nabilone
(7379)II Phencyclidine
(7471)II Cocaine
(9041)II Codeine
(9050)II Diprenorphine
(9058)II Oxycodone
(9143)II Hydromorphone
(9150)II Diphenoxylate
(9170)II Ecgonine
(9180)II Ethylmorphine
(9190)II Hydrocodone
(9193)II Levorphanol
(9220)II Meperidine
(9230)II Methadone
(9250)II Morphine
(9300)II Thebaine
(9333)II Opium, powdered
(9639)II Levo-alphacetylmethadol
(9648)II Oxymorphone
(9652)II Fentanyl
(9801)II The company plans to import the listed controlled substances for sale to research facilities for drug testing and analysis. Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic classes of controlled substances may file comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43, and in such form as prescribed by 21 CFR 1316.47. Any such comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than [insert date 30 days from date of publication]. This procedure is to be conducted simultaneously with, and independent of, the procedures described in 21 CFR 1301.34(b), (c), (d), (e), and (f). As noted in a previous notice published in the **Federal Register** on September 23, 1975, (40 FR 43745-46), all applicants for registration to import a basic class of any controlled substance in schedule I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and
(f)are satisfied. Dated: February 15, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2011-3945 Filed 2-22-11; 8:45 am]
Connectionstraces to 6
Traces to 6 documents
Citation graph
cites case law
Notices
DEPARTMENT OF JUSTICE
Cites 6Cited by 0 across 0 sources